Beryl Drugs reports standalone net profit of Rs 0.01 crore in the September 2025 quarter
Sales decline 8.73% to Rs 5.12 crore
Net profit of Beryl Drugs remain constant at Rs 0.01 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 8.73% to Rs 5.12 crore in the quarter ended September 2025 as against Rs 5.61 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales5.125.61 -9 OPM %14.269.98 -PBDT0.650.44 48 PBT0.260.11 136 NP0.010.01 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2025 | 7:39 AM IST